2. Introduction: MAST 1 Study
Prospective evaluation of 53 consecutive patients with nanoFLEX
(STAAR aspheric single piece collamer iol) between 7/09 and
5/10 (Lipstock)
Measured 6-8 weeks Post-Op
(“nanoFLEX MAST”)
Prospective evaluation of 47 consecutive patients presenting in
office for routine follow up 7/09 to 5/10
All with STAAR non-aspheric collamer plate IOL(CC4204BF) from 7/01 to 1 1/08
(Lipstock)
(“BF MAST”)
3. MAST 1 Study
Distance-Corrected Bilateral Average Near (40cm) &
Intermediate (80cm) Visual Acuity
0
10
20
30
40
50
60
nanoFLEX nanoFLEX
20/20 Subset
BF Spherical
SnellenAcuity20/-
Near
Intermediate
20/53 20/53 20/52
20/24 20/24
20/26
4. MAST 2 STUDY
To evaluate the near and intermediate
visual outcomes of patients undergoing
routine cataract surgery with
phacoemulsification and monofocal IOL
placement in the capsular bag in at least
one eye
Purpose:
5. Methods
Prospective, multicenter evaluation of over 100
consecutive patients undergoing cataract surgery
with different monofocal IOLs
Study evaluation consisted of a single visit 1-2
months postoperatively
Outcome measures included monocular DC near
and intermediate VA and binocular acuities if eyes
were bilaterally implanted with the same lens
6. Inclusion Criteria
Patients who underwent routine cataract surgery
with phacoemulsification and monofocal IOL
placement in the capsular bag in at least one eye
within the last 36 months
At least 1 month postop before follow-up evaluation
All Patients must have a DCVA of 20/25 or better
8. NanoFLEX Binocular VA at Near (40cm) and
Intermediate (80 cm)
0%
5%
10%
15%
20%
25%
30%
35%
40%
45%
50%
20/16 20/20 20/25 20/32 20/40 20/50 20/63 20/80
10%
22%
48%
21%
2%
10%
21%
40%
24%
5%
%ofPatients
Intermediate (Average = 20/24) Near ( Average = 20/50)
n = 63
9. NanoFLEX Binocular VA at Near (40cm) and
Intermediate (80 cm) – Cumulative Eyes
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
20/16 20/20 20/25 20/32 20/40 20/50 20/63 20/80
10%
32%
79%
100%
2%
11%
32%
71%
95%
100%
%ofPatients
Intermediate ( Average = 20/24) Near (Average = 20/50)
n = 63
10. All Lenses
Distance-Corrected Bilateral Average Near & Intermediate VA
0
10
20
30
40
50
60
Near Intermediate
SnellenAcuity20/-
NanoFLEX (n=63)
AMO Tecnis
sililcone aspheric 3
piece iol (n=61)
20/50
20/24
20/28
20/52
p = 0.832
p = 0.072
11. Binocular VA at Near (40 cm): All Lenses
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
20/40 or
Better
20/50 or
Better
20/63 or
Better
20/80 or
Better
32%
71%
95%
100%
46%
72%
79%
93%
%ofPatients
NanoFLEX (n=63)
AMO Tecnis sililcone aspheric 3
piece iol (n=61)
p = 0.006
p = 0.112
12. Binocular VA at Intermediate (80 cm): All Lenses
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
20/20 or Better 20/25 or Better 20/32 or Better 20/40 or Better
35%
79%
100% 100%
34%
74%
82%
93%
%ofPatients
NanoFLEX (n=63)
AMO Tecnis sililcone aspheric 3
piece iol (n=61)
p = <0.001
13. Comparison to Multifocal and
Accommodative IOLs
Lens Investigator
Binocular
Distance Corrected
Near VA at 40cm
Binocular
Distance Corrected
Intermediate VA at 80cm
NanoFlex Lipstock 20/50 20/24
Restor D1
Santhiago 20/21 -
Maxwell - 20/30 at 70cm
Alfonso 20/18 20/28 at 70cm
Kohnen 20/22 20/29 at 70cm
Tecnis MF Hutz 20//27 20/26
Crystalens
Pepose 20/32 20/17
Alio 20/25 -
Synchrony Bohorquez 20/27 -
14. Conclusions
The nanoFLEX lens offers patients a highly
effective cost-effective alternative to the “premium
channel” IOLs, by providing some near vision
and excellent intermediate vision.
An additional prospective study designed to
evaluate how best to utilize the intrinsic properties
of the nanoFLEX to optimize visual outcomes with
a “blended vision” approach was subsequently
conducted.